openPR Logo
Press release

HyperVisual AI Secures Investment from K-Ground Ventures Innovation IP Fund for On-Device AI Vision Intelligence

06-02-2025 08:26 PM CET | Politics, Law & Society

Press release from: ABNewswire

HyperVisual AI Secures Investment from K-Ground Ventures

HyperVisual AI, a startup developing on-device vision intelligence solutions that apply AI technology directly on edge devices without relying on cloud connectivity, announced on June 2nd that it has secured investment from K-Ground Ventures, a leading VC in deep tech commercialization in Korea and the first operator of the Scale-up TIPS program.

Image: https://www.abnewswire.com/upload/2025/06/8678f7277074e2c486f3221a993b081f.jpg

Photo: K-Ground Ventures CEO Nam-Hoon Cho (left) and HyperVisual AI CEO Sam-Yun Jung (right) Photo credit: HyperVisual AI

Founded in 2023, HyperVisual AI is a semiconductor-based AI startup that is developing a General-Purpose Neural Processing Unit (GPNPU)-an AI processor operable on-device-as well as proprietary AI models and frameworks. Their GPNPU architecture, a hybrid structure combining general-purpose GPU computing (GPGPU) and Neural Processing Units (NPU) into a single core, enables efficient low-power AI computation. This technology is considered highly optimized for on-device environments. The company was recently selected for the Ministry of SMEs and Startups' "1000+ Super Gap Startups" program, drawing significant interest from fabless firms, VCs, and investors.

CEO Samyun Jung of HyperVisual AI stated that "We are pleased to have our patent value highly recognized and to have secured investment from the K-Ground Innovation IP Fund, which specializes in deep tech IP investments. HyperVisual AI is actively conducting joint development projects with client companies in the on-device AI industry, where convergent technologies are the key to competitiveness. With our outstanding R&D capabilities and Korea's deep tech infrastructure, we aim to grow into a global hybrid vision intelligence total solution provider through collaboration with clients and investors."

Nam-Hoon Cho, CEO of K-Ground Ventures and a leading expert in deep tech technology commercialization, said, "We have long recognized the GPNPU hybrid architecture technology of HyperVisual AI as an innovative IP and technology that can lead the future on-device market. Based on mentorship and business support, we decided to proceed with the investment. The target markets for on-device applications-mobile, consumer electronics, mobility, and robotics-are areas where Korean companies are particularly strong. We believe that competitive Korean firms can lead the global market through convergent technology. Bold government policy support is needed to establish a new ecosystem that will lead the global on-device AI market, which is expected to become a next-generation growth engine."

K-Ground Ventures also announced that, through this investment, it plans to build an on-device semiconductor alliance in collaboration with organizations like the Fabless Industry Association, and actively work to discover, invest in, and foster innovative companies.

According to a Deloitte report, the on-device AI market is expected to grow rapidly at an annual rate of 27.95%, reaching USD 16.7 billion by 2031.

Attachment 1: Introduction to HyperVisual AI Technology

The GPNPU architecture currently under development is designed so that the GPU and NPU share memory, with each handling parallel and matrix operations, respectively. This approach resolves bottlenecks, memory access delays, and complex pipeline issues common in traditional heterogeneous computing architectures (CPU, DSP, NPU), significantly improving power efficiency.

Moreover, GPNPU is designed to support not only Vision Transformers but also multimodal and cross-modal AI architectures on edge devices, showing strong potential for future scalability.

Based on this technological foundation, the company plans to complete GPNPU IP design by 2025 and begin commercializing its semiconductor IP in 2026. The ultimate goal is to secure technological leadership in the on-device AI market with a total vision intelligence solution that integrates their proprietary processor and models.

Image: https://www.abnewswire.com/upload/2025/06/4710f80bed6159e3345e70d6c2a9ed9c.jpg

Media Contact
Company Name: HyperVisual AI
Contact Person: Samyun Jung, CEO
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hypervisual-ai-secures-investment-from-kground-ventures-innovation-ip-fund-for-ondevice-ai-vision-intelligence]
Country: South Korea
Website: http://www.hypervisualai.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HyperVisual AI Secures Investment from K-Ground Ventures Innovation IP Fund for On-Device AI Vision Intelligence here

News-ID: 4047678 • Views:

More Releases from ABNewswire

What are the most effective medical therapies for managing excess body mass? Regenerative Medicine Advances Transform Cape Coral Weight Management Programs
What are the most effective medical therapies for managing excess body mass? Reg …
Cape Coral healthcare providers report breakthrough success using FDA-approved GLP-1 medications for weight management, with Premier Wellness Florida leading comprehensive treatment programs combining pharmaceuticals with holistic wellness support. Cape Coral, FL - Recent clinical developments in medical weight management have prompted Southwest Florida healthcare providers to report significant patient success rates with FDA-approved medications and comprehensive treatment protocols. Premier Wellness Florida, operating from its Del Prado Boulevard facility, has documented patient
Winkler Kurtz LLP - Long Island Lawyers Port Jefferson Station Injury Attorney Offering Trusted Legal Support
Winkler Kurtz LLP - Long Island Lawyers Port Jefferson Station Injury Attorney O …
Winkler Kurtz LLP is a leading Long Island law firm specializing in personal injury cases such as car accidents, slip and falls, and medical malpractice. Offering decades of local experience, the firm provides compassionate support and skilled legal advocacy to help injury victims secure justice and compensation. With free consultations and a contingency fee policy, Winkler Kurtz LLP ensures quality legal help is available to all Long Islanders in need. When
How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious

All 5 Releases